Voriconazole: Difference between revisions

From IDWiki
()
No edit summary
Line 1: Line 1:
  +
== Dosing ==
== Dose Adjustment Guidelines ==
 
   
 
{| class="wikitable"
 
{| class="wikitable"
Line 23: Line 23:
 
| Hold dose. Follow daily trough levels, then restart when trough is ≤2.5 at a dose decreased by 50%. Recheck trough level on day 5 of new regimen.
 
| Hold dose. Follow daily trough levels, then restart when trough is ≤2.5 at a dose decreased by 50%. Recheck trough level on day 5 of new regimen.
 
|}
 
|}
  +
  +
== Adverse Effects ==
  +
  +
* Visual
  +
** Floaters etc that may improve with time
  +
** Visual hallucinations
  +
* Hepatotoxicity
  +
* QTc prolongation
   
 
== Further Reading ==
 
== Further Reading ==

Revision as of 16:57, 10 September 2019

Dosing

Trough (mcg/mL) Recommendation
0.0 to 0.6 Increase dose by 100 mg and recheck trough on day 5 of new regimen
0.7 to 0.9 Increase dose by 50 mg and recheck trough on day 5 of new regimen
1.0 to 4.0 At target, no dose adjustment needed
4.1 to 5.5 Decrease dose by 50 mg and recheck trough on day 5 of new regimen
5.6 to 7.9 Hold dose. Follow daily trough levels, then restart when trough is ≤2.5 at a dose decreased by 100 mg. Recheck trough on day 5 of new regimen.
≥8.0 Hold dose. Follow daily trough levels, then restart when trough is ≤2.5 at a dose decreased by 50%. Recheck trough level on day 5 of new regimen.

Adverse Effects

  • Visual
    • Floaters etc that may improve with time
    • Visual hallucinations
  • Hepatotoxicity
  • QTc prolongation

Further Reading

References

  1. ^  Romeo-Gabriel Mihăilă. Voriconazole and the liver. World Journal of Hepatology. 2015;7(13):1828. doi:10.4254/wjh.v7.i14.1828.